In conclusion, NDE1 has the potential to be a target for immunotherapy since it is associated with the percentage of cancer cells in tumours and other genomic abnormalities, such as spontaneous loss of nucleotides in repetitive DNA strands. Here, NDE1 is linked to cancer.